trending Market Intelligence /marketintelligence/en/news-insights/trending/Lx3kJnTc-SGzyqfcM94RDw2 content esgSubNav
In This List

Health Canada approves Pediapharm ear infection drug

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Health Canada approves Pediapharm ear infection drug

Health Canada approved Pediapharm Inc.'s Otixal for the treatment of acute otitis media with tympanostomy tubes in pediatric patients.

Otixal is an antibiotic and steroid combination ear drop.